Monkeypox Virus (MPV) Detection Kit (PCR Fluorescence Probing) is designed to detect DNA from MPV in specimens such as serum or plasma, vesicular or pustular lesion fluid collected from individuals. The kit is based on real-time PCR fluorescence technology, and the specific primers and corresponding fluorescent probes target to the conserved region of MPV are designed for highly specific detection. By detecting the fluorescent signals changes, the MPV nucleic acid from specimen can be qualitatively detected.
The Monkeypox Virus Real Time PCR kit is used for the detection of Monkeypox virus in serum or lesion exudate samples by using real time PCR systems
 

• Rapid - Completes the entire process from extraction to amplification within a minimum of 45 minutes
• Flexible - Three specifications fulfill different demands
• Accurate - Assay sensitivity of 200 copies/mL
• Specimen requirement - Serum or plasma, vesicular or pustular lesion fluid

• 50 tests/kit & 200 tests/kit
• Specimen requirement: Serum or plasma, vesicular or pustular lesion fluid
• Applicable Instruments: MA-6000, ABI series, Bio-Rad series, Roche LightCycler R480, Cepheid SmartCycler, Rotor-Gene series and other multi-channel real-time quantitative PCR instruments.

Changsha Renji Medical Equipment Co., Ltd. is a medical consumable products industrial chain company with developing and manufacturing a complete product line for molecular laboratories, ranging from upstream consumable medical products, nucleic acid extraction kits and full automatic instruments to downstream real time PCR diagnostic & research kits and fluorescence systems. 
Based on innovative R&D center in Changsha, China, Renji understands its capability and social responsibility to offer molecular diagnostic products consistent in quality, accurate and reliable in test results, easy to use and accessible to laboratories of all levels despite their variety in lab environment. Renji is gradually winning its reputation all over the world through growing influence on popularizing RT-PCR technologies towards they are supposed to be as affordable and accessible human health care means. 
In the future ,"RENJI" will be committed to integrating the development of enterprise into the national health industry development strategy, building a new pattern of innovation and development and building a new high ground of modern medical plastics industry chain. "RENJI" will bear in mind the original intention that quality is the survival foundation of enterprise and product is equal to people' s charter to build "RENJI" brand and make progress hands in hands with counterparts at home and abroad for contribution to the human health.